Navigation Links
Measuring snow with a bucket, a windmill, and the sun?
Date:4/22/2009

In Maine, government scientists have figured out how to measure snowfall in remote areas with a bucket, a small windmill, and the sun - all the while saving money, energy, and, ultimately helping to save lives.

What led to this energy-efficient ingenuity was the need to help the National Weather Service forecast and predict the risk of floods from spring snowmelt.

The problem was this: While the USGS has about 15 snowmelt measurement sites in Maine, they also needed a way to measure snowfall in remote areas where power grids are scarce. Emergency managers need accurate information to prepare for forthcoming hazards and energy companies need to plan ahead for how much water to expect in reservoirs.

"We needed to find an alternative power source," said Bob Lent, chief of the USGS Maine Water Science Center in Augusta. "So we cobbled together a small-scale commercial windmill to replace commercial AC power, and supplemented the windmill with solar panels. What we ended up with is a windmill that powers our measurements on windy and cloudy days, and solar panels that power them on calm, sunny days," said Lent. "And," he added, "not only will we get more accurate information, but the systems will pay for themselves in about 3 to 4 years since using the electricity-dependent devices cost between $200 and $400 a year."

A prototype system has been housed in use at the USGS office in Augusta for the past winter. It has proved so accurate, said Lent, that the USGS plans to install four snowfall sites around the state this summer using the same system.

Basically, the system looks like this: a gage is attached to a 5-gallon bucket that sits atop a simple wooden platform on a metal pole. The gage has a heating element to melt the snow as it collects in the cone of the bucket. The gage only turns on when snow is detected. Nearby is a data-collection box that is linked to the windmill and solar panels. When the bucket fills up with
'/>"/>

Contact: Bob Lent
rmlent@usgs.gov
207-622-8202 x102
United States Geological Survey
Source:Eurekalert

Page: 1 2

Related biology news :

1. Measuring molecules to improve drug design
2. Measuring water from space
3. Measuring calcium in serpentine soils
4. Measuring the stress of forested areas
5. Biosensor for measuring stress in cells
6. New approach to measuring carbon in forests
7. Positron emission tomography superior to standard evaluation tools in measuring treatment response
8. Atmospheric measuring device for understanding smog formation
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Biology News(10 mins):New understanding of how to prevent destruction of a tumor suppressor 2Study shows nearly 1/3 of human genome is involved in gingivitis 2Study shows nearly 1/3 of human genome is involved in gingivitis 3Einstein receives high-risk/high-reward cancer research funding 2Einstein receives high-risk/high-reward cancer research funding 3Neurobiological Technologies Partner Celtic Pharma Announces Results of XERECEPT 28R 29 Phase 3 Clinical Program 4501 1Neurobiological Technologies Partner Celtic Pharma Announces Results of XERECEPT 28R 29 Phase 3 Clinical Program 4501 2Neurobiological Technologies Partner Celtic Pharma Announces Results of XERECEPT 28R 29 Phase 3 Clinical Program 4501 3Neurobiological Technologies Partner Celtic Pharma Announces Results of XERECEPT 28R 29 Phase 3 Clinical Program 4501 4Neurobiological Technologies Partner Celtic Pharma Announces Results of XERECEPT 28R 29 Phase 3 Clinical Program 4501 5Neurobiological Technologies Partner Celtic Pharma Announces Results of XERECEPT 28R 29 Phase 3 Clinical Program 4501 6Neurobiological Technologies Partner Celtic Pharma Announces Results of XERECEPT 28R 29 Phase 3 Clinical Program 4501 7Worth of Sigmoidoscopy Screening for Colon Cancer Still Uncertain 47450 1Worth of Sigmoidoscopy Screening for Colon Cancer Still Uncertain 47450 2Worth of Sigmoidoscopy Screening for Colon Cancer Still Uncertain 47450 3Bayer and Onyx Initiate Phase 3 Trial of Nexavar in Non Small Cell Lung Cancer 47446 1Bayer and Onyx Initiate Phase 3 Trial of Nexavar in Non Small Cell Lung Cancer 47446 2Bayer and Onyx Initiate Phase 3 Trial of Nexavar in Non Small Cell Lung Cancer 47446 3Bayer and Onyx Initiate Phase 3 Trial of Nexavar in Non Small Cell Lung Cancer 47446 4Bayer and Onyx Initiate Phase 3 Trial of Nexavar in Non Small Cell Lung Cancer 47446 5